Cromwell Holdings’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.8K Buy
287
+58
+25% +$5.09K 0.01% 562
2026
Q1
$20.8K Buy
229
+5
+2% +$459 0.01% 552
2025
Q4
$20.2K Sell
224
-469
-68% -$44.5K 0.01% 564
2025
Q3
$68.4K Buy
693
+505
+269% +$50K 0.04% 413
2025
Q2
$17.2K Sell
188
-13
-6% -$1.26K 0.01% 569
2025
Q1
$22.8K Sell
201
-472
-70% -$50.5K 0.01% 553
2024
Q4
$71.3K Buy
673
+494
+276% +$53K 0.04% 366
2024
Q3
$19.4K Sell
179
-132
-42% -$14.4K 0.01% 574
2024
Q2
$33.8K Buy
+311
New +$36.7K 0.02% 516

Other funds holding ZBH

Cromwell Holdings's ZBH Position: Q2 2026 in Review

Cromwell Holdings increased its Zimmer Biomet (ZBH) stake by 25% in Q2 2026, buying an estimated $5.09K and bringing the position to 287 shares worth $24.8K. The position accounts for 0.01% of the portfolio, ranked #562.

Cromwell Holdings first reported a position in ZBH in Q2 2024 and has held it in 9 quarters since. The position peaked at $71.3K in Q4 2024. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Cromwell Holdings held 287 shares of Zimmer Biomet worth $24.8K as of Q2 2026.
  • Cromwell Holdings bought 58 Zimmer Biomet shares in Q2 2026, an estimated $5.09K.
  • Zimmer Biomet made up 0.01% of Cromwell Holdings's portfolio in Q2 2026, its #562 holding.
  • Cromwell Holdings first reported a position in Zimmer Biomet in Q2 2024 and has held it in 9 quarters since.
  • Cromwell Holdings's Zimmer Biomet position peaked at $71.3K in Q4 2024.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.